HK1015681A1 - Rate-controlled transdermal administration of risperidone - Google Patents
Rate-controlled transdermal administration of risperidoneInfo
- Publication number
- HK1015681A1 HK1015681A1 HK99100698A HK99100698A HK1015681A1 HK 1015681 A1 HK1015681 A1 HK 1015681A1 HK 99100698 A HK99100698 A HK 99100698A HK 99100698 A HK99100698 A HK 99100698A HK 1015681 A1 HK1015681 A1 HK 1015681A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- risperidone
- rate
- transdermal administration
- controlled transdermal
- controlled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95200867 | 1995-04-06 | ||
PCT/EP1996/001421 WO1996031201A1 (en) | 1995-04-06 | 1996-03-29 | Rate-controlled transdermal administration of risperidone |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1015681A1 true HK1015681A1 (en) | 1999-10-22 |
Family
ID=8220172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK99100698A HK1015681A1 (en) | 1995-04-06 | 1999-02-20 | Rate-controlled transdermal administration of risperidone |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0879051B9 (da) |
JP (1) | JPH11503138A (da) |
KR (1) | KR100437672B1 (da) |
AR (1) | AR003413A1 (da) |
AT (1) | ATE242631T1 (da) |
CA (1) | CA2214420A1 (da) |
CY (1) | CY2388B1 (da) |
DE (1) | DE69628672T2 (da) |
DK (1) | DK0879051T3 (da) |
ES (1) | ES2201176T3 (da) |
HK (1) | HK1015681A1 (da) |
HR (1) | HRP960154A2 (da) |
IL (1) | IL117809A (da) |
PT (1) | PT879051E (da) |
TW (1) | TW592729B (da) |
WO (1) | WO1996031201A1 (da) |
ZA (1) | ZA962752B (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10042412B4 (de) * | 2000-08-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung |
US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
ES2317138T3 (es) | 2004-11-22 | 2009-04-16 | Hisamitsu Pharmaceutical Co., Inc. | Parche transdermico que comprende un agente de diminucion del punto de fusion. |
JP4914826B2 (ja) * | 2005-02-28 | 2012-04-11 | 久光製薬株式会社 | 経皮吸収製剤 |
WO2007035942A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | Transdermal risperidone delivery system |
ES2456328T3 (es) | 2006-06-09 | 2014-04-22 | Dainippon Sumitomo Pharma Co., Ltd. | Preparación de cinta |
DE102007006244B4 (de) | 2007-02-08 | 2012-03-15 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe |
EP2230911A4 (en) * | 2007-12-21 | 2013-07-03 | Zars Pharma Inc | STAMPS, FORMULATIONS, AND RELATED METHODS FOR THE TRANSDERMAL DELIVERY OF ALPRAZOLAM AND OTHER MEDICAMENTS |
WO2010098261A1 (ja) * | 2009-02-24 | 2010-09-02 | 久光製薬株式会社 | リスペリドン含有経皮吸収型製剤及びこれを用いた貼付剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3854480A (en) * | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
US4710191A (en) * | 1985-12-16 | 1987-12-01 | Jonergin, Inc. | Therapeutic device for the administration of medicaments |
US4938759A (en) * | 1986-09-02 | 1990-07-03 | Alza Corporation | Transdermal delivery device having a rate controlling adhesive |
US5788983A (en) * | 1989-04-03 | 1998-08-04 | Rutgers, The State University Of New Jersey | Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes |
CA2065375A1 (en) * | 1989-08-21 | 1991-02-22 | Richard J. Sharpe | Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists |
-
1996
- 1996-03-22 TW TW085103448A patent/TW592729B/zh not_active IP Right Cessation
- 1996-03-29 ES ES96908146T patent/ES2201176T3/es not_active Expired - Lifetime
- 1996-03-29 JP JP8529968A patent/JPH11503138A/ja active Pending
- 1996-03-29 CA CA002214420A patent/CA2214420A1/en not_active Abandoned
- 1996-03-29 EP EP96908146A patent/EP0879051B9/en not_active Expired - Lifetime
- 1996-03-29 DE DE69628672T patent/DE69628672T2/de not_active Expired - Lifetime
- 1996-03-29 AT AT96908146T patent/ATE242631T1/de not_active IP Right Cessation
- 1996-03-29 WO PCT/EP1996/001421 patent/WO1996031201A1/en active IP Right Grant
- 1996-03-29 PT PT96908146T patent/PT879051E/pt unknown
- 1996-03-29 DK DK96908146T patent/DK0879051T3/da active
- 1996-03-29 KR KR1019970706213A patent/KR100437672B1/ko not_active IP Right Cessation
- 1996-04-02 HR HR95.200.867.0A patent/HRP960154A2/hr not_active Application Discontinuation
- 1996-04-03 AR ARP960102078A patent/AR003413A1/es active IP Right Grant
- 1996-04-03 IL IL11780996A patent/IL117809A/xx not_active IP Right Cessation
- 1996-04-04 ZA ZA9602752A patent/ZA962752B/xx unknown
-
1999
- 1999-02-20 HK HK99100698A patent/HK1015681A1/xx not_active IP Right Cessation
-
2003
- 2003-11-04 CY CY0300076A patent/CY2388B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0879051B1 (en) | 2003-06-11 |
DE69628672D1 (de) | 2003-07-17 |
KR100437672B1 (ko) | 2004-09-10 |
EP0879051B9 (en) | 2004-03-03 |
AR003413A1 (es) | 1998-08-05 |
DK0879051T3 (da) | 2003-09-29 |
IL117809A0 (en) | 1996-08-04 |
WO1996031201A1 (en) | 1996-10-10 |
ATE242631T1 (de) | 2003-06-15 |
ES2201176T3 (es) | 2004-03-16 |
EP0879051A1 (en) | 1998-11-25 |
HRP960154A2 (en) | 1997-08-31 |
IL117809A (en) | 2000-10-31 |
CA2214420A1 (en) | 1996-10-10 |
ZA962752B (en) | 1997-10-06 |
AU696789B2 (en) | 1998-09-17 |
AU5149296A (en) | 1996-10-23 |
CY2388B1 (en) | 2004-09-10 |
JPH11503138A (ja) | 1999-03-23 |
PT879051E (pt) | 2003-10-31 |
DE69628672T2 (de) | 2004-04-29 |
TW592729B (en) | 2004-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7070596A (en) | Transdermal administration of olanzapine | |
EP0831845A4 (en) | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | |
AU7236596A (en) | Transdermal administration of ropinirole and analogs thereof | |
IL117728A0 (en) | Pharmaceutical compositions for transdermal administration | |
ZA928011B (en) | Transdermal administration of melatonin. | |
EP0535111A4 (en) | Transdermal administration of buprenorphine | |
AU5397996A (en) | Iontophoretic transdermal system for the administration of at least two substances | |
AU1041599A (en) | Therapeutic uses of triazolo-pyridazine derivatives | |
EP0941039A4 (en) | TRANSDERMAL ADMINISTRATION OF 7alpha-METHYL-19-NORTESTOSTERONE ("MENT") | |
HK1043042A1 (zh) | 含有阿莫西林和棒酸鹽的藥用加工製劑 | |
HUP9900751A3 (en) | Stable pharmaceutical forms of administration containing parathormone | |
PL314637A1 (en) | Adjuvant drug with derivatives of paklitaxel | |
AU2782592A (en) | Thermal enhancement of transdermal drug administration | |
AU6934691A (en) | Transdermal administration of zwitterionic drugs | |
AU2939897A (en) | Administration of histamine for therapeutic purposes | |
HUP0001263A3 (en) | Methods of therapeutic administration of anti-cd4ol compounds | |
HK1015681A1 (en) | Rate-controlled transdermal administration of risperidone | |
ZA96452B (en) | Dematological use of vitamin d derivatives | |
GB9601186D0 (en) | Administration of Drugs | |
AU6821196A (en) | Transdermal administration of vorozole | |
GB9524942D0 (en) | Drug therapy | |
GB9621419D0 (en) | 3-3-disubstituted piperidine derivatives and their use as therapeutic agents | |
IL116615A (en) | Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its salts | |
IL126778A0 (en) | Administration of histamine for therapeutic purposes | |
SI0859595T1 (en) | Therapeutic preparation for the transdermal administration of active substances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080329 |